Croatia power consumption - Sep 23, 2023
Serbia power consumption - Sep 23, 2023
Bulgaria power consumption - Sep 23, 2023
Romania's OPCOM electricity spot volumes - Sep 24, 2023
Romania's OPCOM electricity spot prices - Sep 24, 2023
Dec 10, 2019 11:37 EEST
December 10 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO Ognyan Donev has acquired 8,511 shares in the company at a weighted average price per share of 3.425 levs ($1.96/1.76 euro).
Donev acquired the shares through deals on the Bulgarian Stock Exchange on December 9, Sopharma said in a bourse filing.
The 8,511 shares are equal to a 0.006% stake in Sopharma.
At the end of September, Donev held a stake of below 5% in Sopharma, according to the company's most recent interim financial statement.
However, Ognyan Donev is indirectly the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.
As at 9:20 CET on Tuesday, Sopharma shares traded 0.29% higher at 3.44 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get two (2) free articles more per month or sign up for
and get unlimited access.
Browse our free newsletter options